Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 56 | 2024 | 13482 | 4.300 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 31 | 2024 | 5388 | 3.400 |
Why?
|
Proto-Oncogene Proteins B-raf | 9 | 2024 | 2054 | 2.000 |
Why?
|
Mesothelioma | 3 | 2024 | 774 | 1.680 |
Why?
|
Pleural Neoplasms | 3 | 2024 | 584 | 1.340 |
Why?
|
Protein Kinase Inhibitors | 19 | 2023 | 5695 | 1.240 |
Why?
|
Carbazoles | 3 | 2024 | 229 | 1.000 |
Why?
|
Drug Resistance, Neoplasm | 11 | 2022 | 5334 | 1.000 |
Why?
|
Piperidines | 4 | 2024 | 1663 | 0.960 |
Why?
|
Pyrazoles | 10 | 2022 | 2030 | 0.880 |
Why?
|
Azetidines | 1 | 2024 | 151 | 0.850 |
Why?
|
Receptor Protein-Tyrosine Kinases | 10 | 2021 | 1621 | 0.850 |
Why?
|
Lactams, Macrocyclic | 6 | 2022 | 318 | 0.790 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.760 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2021 | 562 | 0.740 |
Why?
|
Pyridazines | 1 | 2021 | 199 | 0.670 |
Why?
|
Aminopyridines | 7 | 2022 | 576 | 0.660 |
Why?
|
Brain Neoplasms | 7 | 2022 | 9064 | 0.660 |
Why?
|
Lactams | 6 | 2022 | 159 | 0.630 |
Why?
|
Gene Rearrangement | 7 | 2024 | 1142 | 0.590 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2020 | 228 | 0.580 |
Why?
|
Gene Amplification | 2 | 2020 | 1088 | 0.580 |
Why?
|
Mutation | 21 | 2024 | 30208 | 0.580 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2024 | 11858 | 0.570 |
Why?
|
Pyridines | 4 | 2020 | 2889 | 0.510 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2021 | 2425 | 0.500 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 168 | 0.490 |
Why?
|
Proto-Oncogene Proteins | 4 | 2021 | 4520 | 0.460 |
Why?
|
Leukemia, Hairy Cell | 1 | 2014 | 82 | 0.460 |
Why?
|
Fever of Unknown Origin | 1 | 2014 | 94 | 0.450 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 735 | 0.450 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2016 | 258 | 0.440 |
Why?
|
Antibiotics, Antitubercular | 1 | 2014 | 100 | 0.440 |
Why?
|
Genomic Instability | 1 | 2017 | 714 | 0.430 |
Why?
|
Puerperal Disorders | 1 | 2016 | 304 | 0.430 |
Why?
|
Oncogene Proteins, Fusion | 6 | 2021 | 1609 | 0.400 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 3664 | 0.400 |
Why?
|
Quinazolines | 1 | 2018 | 1366 | 0.390 |
Why?
|
Prognosis | 12 | 2020 | 29904 | 0.370 |
Why?
|
Humans | 72 | 2024 | 766000 | 0.350 |
Why?
|
Radiology | 1 | 2023 | 2105 | 0.330 |
Why?
|
Immunocompromised Host | 1 | 2014 | 865 | 0.320 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2014 | 836 | 0.290 |
Why?
|
Pyrimidinones | 2 | 2020 | 384 | 0.280 |
Why?
|
Immunotherapy | 3 | 2023 | 4746 | 0.270 |
Why?
|
Melanoma | 3 | 2023 | 5695 | 0.260 |
Why?
|
Choice Behavior | 1 | 2011 | 845 | 0.230 |
Why?
|
Imidazoles | 2 | 2021 | 1169 | 0.230 |
Why?
|
Pyridones | 2 | 2020 | 817 | 0.230 |
Why?
|
Career Choice | 1 | 2011 | 768 | 0.230 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13634 | 0.220 |
Why?
|
Neoplasm Metastasis | 5 | 2024 | 4886 | 0.220 |
Why?
|
Mycobacterium tuberculosis | 1 | 2014 | 1910 | 0.210 |
Why?
|
Adenocarcinoma | 2 | 2018 | 6361 | 0.210 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3236 | 0.200 |
Why?
|
Genomics | 3 | 2020 | 5924 | 0.200 |
Why?
|
Carbamates | 1 | 2024 | 191 | 0.200 |
Why?
|
Maximum Tolerated Dose | 1 | 2024 | 895 | 0.190 |
Why?
|
Neoplasms | 4 | 2022 | 22336 | 0.190 |
Why?
|
Smoking | 1 | 2019 | 9076 | 0.190 |
Why?
|
Attitude to Health | 1 | 2011 | 2020 | 0.190 |
Why?
|
Meningeal Carcinomatosis | 1 | 2021 | 65 | 0.180 |
Why?
|
Sulfones | 3 | 2018 | 447 | 0.170 |
Why?
|
Pyrimidines | 5 | 2020 | 3048 | 0.170 |
Why?
|
Carcinoma | 2 | 2021 | 2313 | 0.170 |
Why?
|
Life Style | 1 | 2011 | 3926 | 0.160 |
Why?
|
Oximes | 1 | 2020 | 305 | 0.160 |
Why?
|
Workflow | 2 | 2022 | 859 | 0.160 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2022 | 455 | 0.160 |
Why?
|
Pulmonary Fibrosis | 1 | 2023 | 503 | 0.160 |
Why?
|
Triazines | 1 | 2021 | 311 | 0.160 |
Why?
|
Benzimidazoles | 1 | 2024 | 862 | 0.150 |
Why?
|
Aged | 20 | 2024 | 171161 | 0.150 |
Why?
|
Amino Acid Substitution | 2 | 2021 | 1742 | 0.150 |
Why?
|
Platinum | 1 | 2019 | 219 | 0.150 |
Why?
|
Carcinoma, Large Cell | 1 | 2018 | 114 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2022 | 9378 | 0.150 |
Why?
|
Genotype | 3 | 2017 | 13029 | 0.150 |
Why?
|
Acrylamides | 1 | 2019 | 260 | 0.140 |
Why?
|
Prostatic Neoplasms | 1 | 2020 | 11092 | 0.140 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5836 | 0.140 |
Why?
|
Students, Medical | 1 | 2011 | 1961 | 0.140 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 209 | 0.140 |
Why?
|
Middle Aged | 19 | 2024 | 223025 | 0.140 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2022 | 1150 | 0.140 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2018 | 225 | 0.140 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 385 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 109 | 0.140 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 949 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2022 | 2510 | 0.130 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59493 | 0.130 |
Why?
|
Female | 27 | 2024 | 396158 | 0.130 |
Why?
|
Male | 22 | 2024 | 363855 | 0.120 |
Why?
|
Benzamides | 1 | 2021 | 1376 | 0.120 |
Why?
|
Adult | 18 | 2024 | 223106 | 0.120 |
Why?
|
Peripartum Period | 1 | 2016 | 137 | 0.120 |
Why?
|
Exanthema | 2 | 2021 | 503 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2020 | 81542 | 0.120 |
Why?
|
Tumor Burden | 1 | 2020 | 1889 | 0.110 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 61 | 0.110 |
Why?
|
Sulfonamides | 1 | 2024 | 1980 | 0.110 |
Why?
|
Sweet Syndrome | 1 | 2014 | 56 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4047 | 0.110 |
Why?
|
Aniline Compounds | 1 | 2019 | 1078 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 940 | 0.110 |
Why?
|
Cell Line, Tumor | 6 | 2021 | 17070 | 0.110 |
Why?
|
Receptor, Notch2 | 1 | 2014 | 90 | 0.110 |
Why?
|
DNA, Neoplasm | 1 | 2018 | 1739 | 0.110 |
Why?
|
Lymphatic Diseases | 1 | 2014 | 317 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2022 | 1920 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2021 | 1252 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2038 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6101 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1068 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2793 | 0.100 |
Why?
|
Alternative Splicing | 2 | 2014 | 1102 | 0.100 |
Why?
|
Alleles | 2 | 2021 | 6892 | 0.100 |
Why?
|
Lung | 3 | 2023 | 10060 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 752 | 0.090 |
Why?
|
Pneumonia | 1 | 2023 | 2158 | 0.090 |
Why?
|
Anecdotes as Topic | 1 | 2011 | 56 | 0.090 |
Why?
|
Piperazines | 1 | 2021 | 2547 | 0.090 |
Why?
|
Molecular Targeted Therapy | 3 | 2018 | 2825 | 0.090 |
Why?
|
Internship and Residency | 1 | 2011 | 5946 | 0.090 |
Why?
|
Cough | 1 | 2014 | 599 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 496 | 0.090 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1036 | 0.080 |
Why?
|
RNA Splicing | 1 | 2013 | 902 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3594 | 0.080 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6307 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2530 | 0.080 |
Why?
|
Cell Lineage | 1 | 2017 | 2574 | 0.080 |
Why?
|
Immunohistochemistry | 1 | 2022 | 11035 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2015 | 1319 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2014 | 3636 | 0.070 |
Why?
|
Mouth Neoplasms | 1 | 2013 | 595 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1883 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8882 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8494 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6840 | 0.070 |
Why?
|
DNA | 1 | 2020 | 7192 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3722 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5791 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2951 | 0.060 |
Why?
|
Antitubercular Agents | 1 | 2014 | 1380 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2014 | 2156 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3529 | 0.060 |
Why?
|
RNA, Viral | 1 | 2013 | 2868 | 0.060 |
Why?
|
Young Adult | 7 | 2021 | 59857 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8925 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8613 | 0.050 |
Why?
|
Mice, Nude | 2 | 2020 | 3610 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2024 | 65199 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2021 | 21072 | 0.050 |
Why?
|
Survival Analysis | 3 | 2021 | 10089 | 0.050 |
Why?
|
Prospective Studies | 2 | 2022 | 54797 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 153 | 0.050 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2043 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 1765 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2021 | 317 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2019 | 4112 | 0.040 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2020 | 101 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 226 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39233 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12975 | 0.040 |
Why?
|
Genes, myc | 1 | 2020 | 391 | 0.040 |
Why?
|
Nausea | 1 | 2021 | 679 | 0.040 |
Why?
|
Gene Fusion | 1 | 2021 | 357 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2018 | 50 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2018 | 11202 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 266 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2022 | 1241 | 0.040 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 1441 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5752 | 0.030 |
Why?
|
Tyrosine | 1 | 2020 | 1427 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3051 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 615 | 0.030 |
Why?
|
Adolescent | 3 | 2020 | 88808 | 0.030 |
Why?
|
Family Characteristics | 1 | 2019 | 1001 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1552 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 30227 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12802 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 904 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1607 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15545 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1240 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 526 | 0.020 |
Why?
|
Pneumonectomy | 1 | 2018 | 1147 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5383 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4262 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3499 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2339 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2014 | 657 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2125 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3605 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6768 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3423 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2016 | 2242 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2945 | 0.020 |
Why?
|
Transplantation Conditioning | 1 | 2015 | 1635 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1742 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9524 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2013 | 1077 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2717 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2013 | 1137 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3623 | 0.020 |
Why?
|
Animals | 4 | 2020 | 168775 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5744 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4860 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2593 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5365 | 0.010 |
Why?
|
Anticoagulants | 1 | 2020 | 4854 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 40100 | 0.010 |
Why?
|
United States | 2 | 2022 | 72916 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22231 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81821 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13272 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6489 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10431 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12128 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6544 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2014 | 7850 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21509 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20135 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20698 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74838 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 14065 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23600 | 0.010 |
Why?
|
Child | 1 | 2018 | 80567 | 0.010 |
Why?
|